Financials
- Market Capitalization 24.67 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-75.3
売上高対価格比率
3 274.39
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.24 USD | +0.64% | -0.33% | +5.48% | +64.36% | 27.35 B USD | ||
| 500 | INSM Insmed Incorporated - Common Stock | 120.44 USD | +1.60% | -2.99% | +22.65% | -25.68% | 26.30 B USD | ||
| 515 | INCY Incyte Corporation - Common Stock | 123.60 USD | -0.62% | -3.26% | +2.81% | +45.46% | 25.05 B USD | ||
| 524 | BNTX BioNTech SE - American Depositary Shares | 101.23 USD | -0.83% | -9.05% | +11.23% | +1.24% | 24.29 B USD |